AGTRAP and neoplasm: In cancer, AGTRAP can promote tumour progression through activation of the MAPK and AKT/mTOR signaling pathways [6,7], but potentially also through regulation of immunological processes, such as T-cell exhaustion or recruitment of pro-inflammatory and immunosuppressive immune cells [6,8].